Joint (NASDAQ:JYNT - Get Free Report) was upgraded by equities research analysts at StockNews.com from a "hold" rating to a "buy" rating in a report released on Friday.
Separately, Roth Mkm decreased their target price on Joint from $16.00 to $15.00 and set a "buy" rating on the stock in a report on Friday, November 8th.
Read Our Latest Report on Joint
Joint Price Performance
Shares of JYNT traded down $0.12 on Friday, reaching $11.10. The company's stock had a trading volume of 23,910 shares, compared to its average volume of 67,853. The stock's 50 day simple moving average is $11.31 and its two-hundred day simple moving average is $12.95. The stock has a market capitalization of $166.28 million, a P/E ratio of -9.78 and a beta of 1.57. Joint has a 12-month low of $8.29 and a 12-month high of $17.82.
Institutional Trading of Joint
Several hedge funds have recently modified their holdings of the company. Price T Rowe Associates Inc. MD raised its stake in Joint by 5.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 17,464 shares of the company's stock valued at $229,000 after purchasing an additional 837 shares in the last quarter. O Brien Greene & Co. Inc raised its position in shares of Joint by 0.9% during the 2nd quarter. O Brien Greene & Co. Inc now owns 115,620 shares of the company's stock valued at $1,626,000 after buying an additional 1,000 shares in the last quarter. BNP Paribas Financial Markets lifted its holdings in shares of Joint by 5.4% in the 3rd quarter. BNP Paribas Financial Markets now owns 22,510 shares of the company's stock valued at $258,000 after acquiring an additional 1,156 shares during the last quarter. FMR LLC grew its position in Joint by 38.0% in the third quarter. FMR LLC now owns 10,787 shares of the company's stock worth $123,000 after acquiring an additional 2,971 shares in the last quarter. Finally, Avondale Wealth Management increased its stake in Joint by 15.8% during the second quarter. Avondale Wealth Management now owns 22,000 shares of the company's stock worth $309,000 after acquiring an additional 3,000 shares during the last quarter. 76.88% of the stock is owned by hedge funds and other institutional investors.
About Joint
(
Get Free Report)
The Joint Corp. operates and franchises chiropractic clinics in the United States. The company operates in two segments, Corporate Clinics and Franchise Operations. The Joint Corp. was incorporated in 2010 and is headquartered in Scottsdale, Arizona.
Further Reading
Before you consider Joint, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Joint wasn't on the list.
While Joint currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
